Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients
With Non-high Risk Neuroblastoma
Can observation instead of therapy reduce the burden of therapy in low-risk brain
cancer patients without affecting survival?
Basic Study Information
Purpose:Location: University of Rochester
This phase III trial studies how well response and biology-based risk factor-guided
works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor
not need treatment until it progresses. In this case, observation may be sufficient.
Measuring biomarkers in tumor cells may help plan when effective treatment is necessary
what the best treatment is. Response and biology-based risk factor-guided therapy
effective in treating patients with non-high risk neuroblastoma and may help to avoid
the risks and side effects related to standard treatment.
Lead Researcher (Principal Investigator)
Lead Researcher: Angela Girvin
Study Contact InformationPhone: (585) 275-5830
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search